CPC: Pulmonary Nodules in an Infliximab-Treated Rheumatoid Arthritis Patient

Anne R. Bass, MD
Anne R. Bass, MD

Program Director Rheumatology Fellowship Program, Hospital for Special Surgery
Associate Attending Physician, Hospital for Special Surgery

Robert Schneider, MD
Robert Schneider, MD

Radiation Safety Officer, Hospital for Special Surgery
Attending Radiologist, Hospital for Special Surgery

Doruk Erkan, MD, MPH
Doruk Erkan, MD, MPH

Associate Attending Rheumatologist, Hospital for Special Surgery
Associate Physician-Scientist, Barbara Volcker Center for Women and Rheumatic Disease

Abraham Sanders, MD; Douglas Flieder, MD; Carl F. Nathan, MD
Weill Medical College of Cornell University

A 78-year-old African-American woman was diagnosed with rheumatoid arthritis (RA) in 1996 after she presented with a symmetrical polyarthritis of the hands. Over the next four years, she was treated with multiple disease-modifying antirheumatic drugs (DMARDs) including methotrexate, hydroxychloroquine, gold, and leflunomide, all of which were stopped due to side effects or lack of response. She was started on low-dose prednisone in 1998, and was also maintained on low-dose azathioprine, which had been initiated in June.

This article appears in HSS Journal: Volume 3, Number 1.
View the full article at springerlink.com.

About the HSS Journal
HSS Journal, an academic peer-reviewed journal, is published twice a year, February and September, and features articles by internal faculty and HSS alumni that present current research and clinical work in the field of musculoskeletal medicine performed at HSS, including research articles, surgical procedures, and case reports.


Related Conditions

Back in the Game Patient Stories: